BIO-TECHNE (TECH) EBIAT: 2009-2025
Historic EBIAT for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to $38.2 million.
- BIO-TECHNE's EBIAT rose 13.65% to $38.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $78.0 million, marking a year-over-year decrease of 48.26%. This contributed to the annual value of $73.4 million for FY2025, which is 56.34% down from last year.
- BIO-TECHNE's EBIAT amounted to $38.2 million in Q3 2025, which was up 316.00% from -$17.7 million recorded in Q2 2025.
- BIO-TECHNE's EBIAT's 5-year high stood at $89.7 million during Q3 2022, with a 5-year trough of -$17.7 million in Q2 2025.
- Its 3-year average for EBIAT is $38.7 million, with a median of $38.2 million in 2025.
- Its EBIAT has fluctuated over the past 5 years, first skyrocketed by 311.26% in 2022, then tumbled by 143.55% in 2025.
- Over the past 5 years, BIO-TECHNE's EBIAT (Quarterly) stood at $80.2 million in 2021, then plummeted by 37.63% to $50.0 million in 2022, then slumped by 45.08% to $27.5 million in 2023, then grew by 27.03% to $34.9 million in 2024, then increased by 13.65% to $38.2 million in 2025.
- Its EBIAT was $38.2 million in Q3 2025, compared to -$17.7 million in Q2 2025 and $22.6 million in Q1 2025.